Kenneth M Zangwill

Summary

Affiliation: Los Angeles Biomedical Research Institute
Country: USA

Publications

  1. ncbi Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans
    Kenneth M Zangwill
    University of California, Los Angeles, CA, USA
    J Infect Dis 197:580-3. 2008
  2. ncbi Paralytic syndromes in children: epidemiology and relationship to vaccination
    Kenneth M Zangwill
    UCLA Center for Vaccine Research, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA 90502, USA
    Pediatr Neurol 42:206-12. 2010
  3. ncbi A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization
    Kenneth M Zangwill
    UCLA Center for Vaccine Research, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Los Angeles, CA, USA
    Pediatrics 122:e1179-85. 2008
  4. ncbi Evaluation of vaccine coverage for low birth weight infants during the first year of life in a large managed care population
    Jagmohan S Batra
    Harbor UCLA Medical Center, Liu Research Building, 1124 W Carson St, Torrance, CA 90502, USA
    Pediatrics 123:951-8. 2009
  5. ncbi Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infants
    Sylvia H Yeh
    UCLA Center for Vaccine Research, Harbor UCLA Medical Center, 1124 W Carson Street, Liu Research Building, Torrance, CA 90502, USA
    Vaccine 21:2627-31. 2003
  6. ncbi Lack of association between hepatitis B birth immunization and neonatal death: a population-based study from the vaccine safety datalink project
    Eileen M Eriksen
    UCLA Center for Vaccine Research, Harbor-UCLA Medical Center, Torrance, CA 90502, USA
    Pediatr Infect Dis J 23:656-62. 2004
  7. ncbi Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination
    Kenneth M Zangwill
    School of Medicine, UCLA Harbor-UCLA Medical Center, Torrance, CA, USA
    Pediatr Infect Dis J 23:189-97. 2004
  8. ncbi Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants
    Kenneth M Zangwill
    UCLA Center for Vaccine Research, Harbor UCLA Medical Center, Liu Research Building, 1124 W Carson Street, Torrance, CA 90502, USA
    Vaccine 21:1894-900. 2003
  9. ncbi Cold-adapted, live attenuated intranasal influenza virus vaccine
    Kenneth M Zangwill
    Harbor-UCLA Medical Center UCLA School of Medicine, Torrance, CA, USA
    Pediatr Infect Dis J 22:273-4. 2003
  10. ncbi Lack of association between rotavirus infection and intussusception: implications for use of attenuated rotavirus vaccines
    Emily J Chang
    UCLA Center for Vaccine Research, Harbor-UCLA Medical Center, Torrance, CA 90502, USA
    Pediatr Infect Dis J 21:97-102. 2002

Detail Information

Publications17

  1. ncbi Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans
    Kenneth M Zangwill
    University of California, Los Angeles, CA, USA
    J Infect Dis 197:580-3. 2008
    ..5-mug-dose groups had a MN GMT > or =1:40, respectively. Five months later, MN GMTs were significantly greater than those after the second dose. (Trial registration: Clinical Trials.gov identifier NCT00240968 .)...
  2. ncbi Paralytic syndromes in children: epidemiology and relationship to vaccination
    Kenneth M Zangwill
    UCLA Center for Vaccine Research, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA 90502, USA
    Pediatr Neurol 42:206-12. 2010
    ....
  3. ncbi A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization
    Kenneth M Zangwill
    UCLA Center for Vaccine Research, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Los Angeles, CA, USA
    Pediatrics 122:e1179-85. 2008
    ..Prelicensure studies of diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus vaccine suggested that there were higher rates of fever after its administration than when its component antigens were given separately...
  4. ncbi Evaluation of vaccine coverage for low birth weight infants during the first year of life in a large managed care population
    Jagmohan S Batra
    Harbor UCLA Medical Center, Liu Research Building, 1124 W Carson St, Torrance, CA 90502, USA
    Pediatrics 123:951-8. 2009
    ..This study assesses and compares age- and dose-specific immunization coverage in children of different birth weight categories during the first year of life...
  5. ncbi Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infants
    Sylvia H Yeh
    UCLA Center for Vaccine Research, Harbor UCLA Medical Center, 1124 W Carson Street, Liu Research Building, Torrance, CA 90502, USA
    Vaccine 21:2627-31. 2003
    ..Streptococcus pneumoniae (Sp) is an important bacterial pathogen in children. Nasopharyngeal (NP) colonization of S. pneumoniae is necessary for person-to-person transmission and often precedes invasive disease...
  6. ncbi Lack of association between hepatitis B birth immunization and neonatal death: a population-based study from the vaccine safety datalink project
    Eileen M Eriksen
    UCLA Center for Vaccine Research, Harbor-UCLA Medical Center, Torrance, CA 90502, USA
    Pediatr Infect Dis J 23:656-62. 2004
    ..CONCLUSIONS: A relationship between HBV and neonatal death was not identified...
  7. ncbi Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination
    Kenneth M Zangwill
    School of Medicine, UCLA Harbor-UCLA Medical Center, Torrance, CA, USA
    Pediatr Infect Dis J 23:189-97. 2004
    ....
  8. ncbi Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants
    Kenneth M Zangwill
    UCLA Center for Vaccine Research, Harbor UCLA Medical Center, Liu Research Building, 1124 W Carson Street, Torrance, CA 90502, USA
    Vaccine 21:1894-900. 2003
    ....
  9. ncbi Cold-adapted, live attenuated intranasal influenza virus vaccine
    Kenneth M Zangwill
    Harbor-UCLA Medical Center UCLA School of Medicine, Torrance, CA, USA
    Pediatr Infect Dis J 22:273-4. 2003
  10. ncbi Lack of association between rotavirus infection and intussusception: implications for use of attenuated rotavirus vaccines
    Emily J Chang
    UCLA Center for Vaccine Research, Harbor-UCLA Medical Center, Torrance, CA 90502, USA
    Pediatr Infect Dis J 21:97-102. 2002
    ..Our data suggest that the association between tetravalent rhesus-human rotavirus vaccine and intussusception may possibly result from the nonhuman rotavirus components of that vaccine...
  11. ncbi Cost-benefit analysis of in-hospital influenza vaccination of postpartum women
    Yao Ding
    Leonard Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, California, USA
    Obstet Gynecol 119:306-14. 2012
    ..To estimate the potential economic benefits associated with hospital-based postpartum influenza vaccination...
  12. ncbi Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine
    John J Treanor
    Department of Medicine, University of Rochester, Rochester, NY, USA
    N Engl J Med 354:1343-51. 2006
    ..Influenza A (H5N1) viruses could cause a severe worldwide epidemic, with high attack rates, large numbers of deaths and hospitalizations, and wide disruption. Effective vaccines against these viruses in humans are urgently needed...
  13. ncbi Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old
    Simon J Hambidge
    Clinical Research Unit, Kaiser Permanente Colorado, Denver, CO 80237 8066, USA
    JAMA 296:1990-7. 2006
    ..Beginning with the winter season of 2004-2005, influenza vaccination has been recommended for all children 6 to 23 months old in the United States. However, its safety in young children has not been adequately studied in large populations...
  14. ncbi Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: a Vaccine Safety Datalink study
    Lisa A Jackson
    Group Health Center for Health Studies, Seattle, Washington, USA
    Pediatrics 118:2032-7. 2006
    ..We conducted a population-based retrospective cohort study to evaluate compliance with the 2-dose trivalent inactivated influenza vaccine recommendations...
  15. ncbi Safety of the trivalent inactivated influenza vaccine among children: a population-based study
    Eric K France
    Clinical Research Unit, Kaiser Permanente Colorado, Denver, USA
    Arch Pediatr Adolesc Med 158:1031-6. 2004
    ..To our knowledge, there are no published population-based studies on the safety of the inactivated trivalent influenza vaccine among children...
  16. ncbi Polio extraimmunization in children younger than 2 years after changes in immunization recommendations
    Loren K Mell
    Center for Health Studies, Group Health Cooperative, Seattle, Washington, USA
    Pediatrics 111:296-301. 2003
    ..CONCLUSIONS: Poliovirus extraimmunization rates have fallen dramatically in association with the change-over to the all inactivated polio virus schedule...
  17. ncbi Compliance with national immunization guidelines for children younger than 2 years, 1996-1999
    Loren K Mell
    Center for Health Studies, Group Health Cooperative, Seattle, Washington, USA
    Pediatrics 115:461-7. 2005
    ..6% of children were compliant with prevailing childhood immunization recommendations from 1996 to 1999. Efforts to improve compliance with guidelines are recommended, to optimize childhood infectious disease prevention...